Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: June 2011
-
BIO and Personalized Medicine By Andrew Williams — The 2011 BIO International Convention in Washington, D.C. begins next week. If you are planning on attending, Patent Docs is highlighting a few sessions, in thematic fashion, to help navigate your way through the convention. Today, in this final installment, we review just a few of the…
-
By Donald Zuhn — Today, in Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., the Federal Circuit affirmed a decision on summary judgment by the District Court for the District of New Jersey that the claims of U.S. Patent No. 5,211,954 were invalid for obviousness. Tyco Healthcare Group LP and Mallinckrodt, Inc. ("Tyco") own the…
-
By Donald Zuhn — BIO Reaffirms Support for H.R. 1249 In a statement released earlier today, the Biotechnology Industry Organization (BIO) reaffirmed its support for H.R. 1249 and urged the House to pass the bill this week. BIO President and CEO Jim Greenwood noted that the organization was "pleased that Judiciary Committee Chairman Lamar Smith…
-
BIO and Biosimilars By Andrew Williams — The 2011 BIO International Convention in Washington, D.C. begins next week. If you are planning on attending, Patent Docs is highlighting a few sessions, in thematic fashion, to help navigate your way through the convention. Last week, we highlighted four sessions on how the Supreme Court is impacting…
-
By Donald Zuhn — H.R. 1249 Floor Debate to Take Place Later This Week? In today's IPO Daily News, the Intellectual Property Owners Association (IPO) reported that floor debate of the House version of the "America Invents Act" (H.R. 1249) is now scheduled to take place "on Wednesday or later in the week." The House…
-
By James DeGiulio — Allergan and Hi-Tech Settle Combigan Patent Dispute Allergan has resolved its dispute with Hi-Tech Pharmacal over the latter's bid to market a generic version of Allergan's glaucoma treatment Combigan. In June 2009, Allergan sued Hi-Tech in the U.S. District Court for the Eastern District of Texas, claiming that Hi-Tech's ANDA filing…
-
David Boundy Thinks So David Boundy (below) of Cantor Fitzgerald and co-author (with Phillip Furlang) of the forthcoming Patent Prosection (Oxford University Press) has been at the forefront of several important patent issues in the past decade, including notably the USPTO's ill-advised "claims and continuation" rules instituted by the Dudas Administration and blocked by Judge…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Somaxon Pharmaceuticals Inc. et al. v. Zydus Pharmaceuticals (USA) Inc. et al.1:11-cv-00537; filed June 16, 2011 in the District Court of Delaware • Plaintiffs: Somaxon Pharmaceuticals Inc.; Procom One Inc.• Defendants: Zydus Pharmaceuticals (USA) Inc.;…
-
Conference organizers have confirmed that the Honorable Ms. Naledi Pandor, Minister of the Department of Science and Technology of South Africa, will be the keynote speaker at the "Accelerating IP and Innovation in South Africa," to be held September 18-20, 2011 at the Cape Sun Hotel in Cape Town, South Africa. Ms. Pandor, who reports…
-
June 19-20, 2011 – IP Business Congress (Intellectual Asset Management magazine) – San Francisco, CA June 21, 2011 – The Impact of Therasence v. Becton on the Doctrine of Inequitable Conduct (LexisNexis) – New York, NY June 21-22, 2011 – 10th Annual Forum on Pharma Patent Lifecycles (C5) – London, England June 22, 2011 –…
Patent Docs 